INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2014

Higher vitamin D levels were linked to lower mortality in cancer patients.

A meta-analysis of prospective cohort studies examined 2,330 colorectal cancer patients and 4,413 breast cancer patients across ten studies. Comparing highest to lowest 25-hydroxyvitamin D categories, pooled hazard ratios were 0.71 (95% CI 0.55-0.91) for overall mortality and 0.65 (95% CI 0.49-0.86) for disease-specific mortality in colorectal cancer. In breast cancer, corresponding hazard ratios were 0.62 (95% CI 0.49-0.78) and 0.58 (95% CI 0.38-0.84).

Shows an association, not proof of cause and effect.

Study type
Meta-analysis of prospective cohort studies
Who was studied
2,330 colorectal and 4,413 breast cancer patients (10 cohort studies)
What was measured
Overall and disease-specific mortality

THE PAPER

Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.

Maalmi H, Ordóñez-Mena JM, Schöttker B, Brenner H. Eur J Cancer, 2014.

PubMed 24582912 ↗DOI 10.1016/j.ejca.2014.02.006 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.